Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript


Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Jefferies Global Healthcare Conference Call November 14, 2023 3:30 AM ET

Company Participants

Stuart Arbuckle – Executive Vice President and Chief Operating Officer

Conference Call Participants

Michael Yee – Jefferies

Michael Yee

All right. Good morning, everybody. Thank you for joining us here on a beautiful morning session here at the Jefferies Global Healthcare Conference here in London. I’m Michael Yee, one of the senior biotechnology analyst here at Jefferies. And I’m really excited to have Stuart Arbuckle, Executive Vice President and Chief Operating Officer of Vertex Pharmaceuticals.

I started — before we jumped on the stage here and I said the amazing thing here about having Vertex is we have a biotech at an all-time high. So that is a great thing here given how challenging it is in the biotech sector. So it is refreshing to have Vertex up here with us. And part of that is because there are so many things going on. So hopefully, we can hit on some of the key topics in just 25 minutes.

Stu, maybe if I turn it over to you, the first thing I would just ask you is to give us a very brief snapshot of some of the things that you’re excited about for 2024, obviously, with CF with — I know people will want to talk briefly about pain. And also, you have a launch coming up for, hopefully, an approval for sickle cell. So a lot going on. Maybe just give us a few brief comments about what you guys are focused on for 2024, and then we’ll get into some of the details.

Stuart Arbuckle

Well, thanks, Mike, for having us. Good morning, everybody. Yes, I know it’s a super exciting time to be at Vertex. We do have a lot going on. Clearly, we are continuing to execute in



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *